(Q39582716)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21368751%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

title

Drug interactions between the immunosuppressant tacrolimus and the cholesterol absorption inhibitor ezetimibe in healthy volunteers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21368751%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21368751%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Werner Weitschies

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21368751%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

author name string

S Oswald

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21368751%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

A Nassif

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21368751%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

C Modess

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21368751%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

A Ulrich

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21368751%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

D Runge

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21368751%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

U Hanke

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21368751%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

D Lütjohann

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21368751%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

A Engel

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21368751%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

W Siegmund

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21368751%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

language of work or name

English

0 references

publication date

2 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21368751%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

24 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21368751%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

volume

89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21368751%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21368751%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

page(s)

524-528

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21368751%20AND%20SRC:MED&resulttype=core&format=json

Immunosuppression: evolution in practice and trends, 1994-2004.

24 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.4

Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.4

Liver transplantation and neurological side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.4

Treatment of hyperlipidemia in cardiac transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.4

Mammalian target of rapamycin inhibitor dyslipidemia in kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.4

Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.4

Statins benefit outcomes of renal transplant recipients on a sirolimus-cyclosporine regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.4

Statin use is associated with prolonged survival of renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.4

Rationale for targeting multiple lipid pathways for optimal cardiovascular risk reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.4

Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.4

Supratherapeutic response to ezetimibe administered with cyclosporine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.4

Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.4

Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.4

Ezetimibe for the treatment of uncontrolled hypercholesterolemia in patients with high-dose statin therapy after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.4

Pharmacokinetic and pharmacodynamic interactions between the immunosuppressant sirolimus and the lipid-lowering drug ezetimibe in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.4

The efficacy and tolerability of ezetimibe in cardiac transplant recipients taking cyclosporin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.4

Characterization of the transport of the bicyclic peptide phalloidin by human hepatic transport proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.4

Drug interactions with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.4

Studies on the interactions between drugs and estrogen. III. Inhibitory effects of 29 drugs reported to induce gynecomastia on the glucuronidation of estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.4

Morphine glucuronosyltransferase activity in human liver microsomes is inhibited by a variety of drugs that are co-administered with morphine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.4

Intestinal expression of P-glycoprotein (ABCB1), multidrug resistance associated protein 2 (ABCC2), and uridine diphosphate-glucuronosyltransferase 1A1 predicts the disposition and modulates the effects of the cholesterol absorption inhibitor ezetim

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.4

Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.4

Treatment of hypercholesterolemia with ezetimibe in the kidney transplant population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.4

Cyclosporin A, but not tacrolimus, inhibits the biliary excretion of mycophenolic acid glucuronide possibly mediated by multidrug resistance-associated protein 2 in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.4

Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: local immunosuppression or islet toxicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.4

Combined therapy with atorvastatin and calcineurin inhibitors: no interactions with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.4

Commonly used nonionic surfactants interact differently with the human efflux transporters ABCB1 (p-glycoprotein) and ABCC2 (MRP2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.4

High-dose statin treatment does not alter plasma marker for brain cholesterol metabolism in patients with moderately elevated plasma cholesterol levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.4

21 January 2018

Identifiers

DOI

10.1038/CLPT.2011.4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21368751%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference